We are live on
!
Find out more
LCG
Lisanti Capital Growth Portfolio holdings
AUM
$397M
1-Year Est. Return
178.66%
This Fund
S&P 500
This Quarter
Est. Return
+20.71%
1 Year Est. Return
+178.66%
3 Year Est. Return
+1,089.72%
5 Year Est. Return
+3,176.57%
10 Year Est. Return
+120,936.2%
AUM
$261M
AUM Growth
+$54.5M
(+26%)
Cap. Flow
+$23.3M
Cap. Flow
% of AUM
8.92%
Top 10 Holdings %
Top 10 Hldgs %
16.93%
Holding
167
New
58
Increased
46
Reduced
31
Closed
28
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
EFOR
Everforth Inc
EFOR
|
+$4.15M |
| 2 |
Chefs' Warehouse
CHEF
|
+$2.9M |
| 3 |
CRZO
Carrizo Oil & Gas Inc
CRZO
|
+$2.9M |
| 4 |
CPE
Callon Petroleum Company
CPE
|
+$2.75M |
| 5 |
PVTL
Pivotal Software, Inc.
PVTL
|
+$2.74M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Qualys
QLYS
|
+$4.03M |
| 2 |
TWOU
2U Inc
TWOU
|
+$3.37M |
| 3 |
SUM
Summit Materials, Inc. Class A Common Stock
SUM
|
+$3.26M |
| 4 |
NVRO
NEVRO CORP.
NVRO
|
+$2.63M |
| 5 |
PRAH
PRA Health Sciences, Inc.
PRAH
|
+$2.53M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.47% |
| 2 | Technology | 22.67% |
| 3 | Consumer Discretionary | 16.21% |
| 4 | Industrials | 12.52% |
| 5 | Financials | 8.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
EPAM Systems
EPAM
$5.51B
| $426K | 0.16% |
+3,430
| New | +$413K |
|
|
VRTU
127
DELISTED
Virtusa Corporation
VRTU
| $425K | 0.16% |
+8,730
| New | +$424K |
|
128
Wolverine World Wide
WWW
$1.61B
| $399K | 0.15% |
+11,480
| New | +$372K |
|
129
Chemed
CHE
$7.07B
| $396K | 0.15% |
+1,230
| New | +$385K |
|
130
Houlihan Lokey
HLI
$8.77B
| $358K | 0.14% |
+6,980
| New | +$334K |
|
|
HRC
131
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
| $352K | 0.13% |
+4,030
| New | +$358K |
|
132
RH
RH
$3.13B
| $343K | 0.13% |
+2,455
| New | +$266K |
|
133
Capri Holdings
CPRI
$1.83B
| $336K | 0.13% |
5,052
-4,738
| -48% | -$310K |
|
134
Medpace
MEDP
$16.1B
| $303K | 0.12% |
+7,050
| New | +$285K |
|
135
A.O. Smith
AOS
$8.17B
| $281K | 0.11% |
4,745
-5,005
| -51% | -$315K |
|
136
Louisiana-Pacific
LPX
$5.06B
| $263K | 0.1% |
+9,650
| New | +$278K |
|
|
GRUB
137
DELISTED
Just Eat Takeaway.com N.V. American Depositary Shares
GRUB
| $215K | 0.08% |
1,024
-3,916
| -79% | -$811K |
|
|
PRFT
138
DELISTED
Perficient Inc
PRFT
| $212K | 0.08% |
+8,030
| New | +$201K |
|
139
Innoviva
INVA
$1.55B
| $202K | 0.08% |
+14,620
| New | +$219K |
|
|
BPMC
140
DELISTED
Blueprint Medicines
BPMC
| – | – |
-24,860
| Closed | -$2.28M |
|
141
Dycom Industries
DY
$12B
| – | – |
-6,450
| Closed | -$694K |
|
|
FARO
142
DELISTED
Faro Technologies
FARO
| – | – |
-14,645
| Closed | -$855K |
|
|
FOLD
143
DELISTED
Amicus Therapeutics
FOLD
| – | – |
-87,495
| Closed | -$1.32M |
|
144
Kennametal
KMT
$2.59B
| – | – |
-36,000
| Closed | -$1.45M |
|
145
Knight Transportation
KNX
$11.3B
| – | – |
-47,340
| Closed | -$2.18M |
|
146
Nektar Therapeutics
NKTR
$2.39B
| – | – |
-470
| Closed | -$749K |
|
147
Nutanix
NTNX
$16B
| – | – |
-16,620
| Closed | -$816K |
|
148
ON Semiconductor
ON
$31.8B
| – | – |
-43,310
| Closed | -$1.06M |
|
149
Patrick Industries
PATK
$2.74B
| – | – |
-38,301
| Closed | -$1.58M |
|
|
150
Qualys
QLYS
$5.1B
| – | – |
-55,360
| Closed | -$4.03M |
|
Similar funds
GF
PIM
EH
TPWA
ECA
DL
STT
VC
Lisanti Capital Growth's Q2 2018 Portfolio in Review
As of Q2 2018, Lisanti Capital Growth held 167 positions worth $261M, up 26% from $207M the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Lisanti Capital Growth deployed $23.3M of net new capital in Q2 2018, opening 58 new positions and adding to 46 existing holdings. Its largest new stake was Everforth Inc: 50,671 shares worth $3.96M.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 23% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Inogen, an estimated $2.52M trimmed.
- Lisanti Capital Growth's largest Q2 2018 buy was Everforth Inc: 50,671 shares worth $3.96M.
- Lisanti Capital Growth added most to Q2 Holdings in Q2 2018, an estimated $2.26M increase.
- Lisanti Capital Growth's biggest Q2 2018 reduction was Inogen, cutting an estimated $2.52M.
- Lisanti Capital Growth fully exited Qualys in Q2 2018, selling an estimated $4.03M.
- Lisanti Capital Growth's ten largest holdings make up 17% of its $261M portfolio in Q2 2018.
- Lisanti Capital Growth opened 58 new positions and closed 28 in Q2 2018.
- Lisanti Capital Growth's portfolio value rose 26% quarter-over-quarter to $261M.
Based on Lisanti Capital Growth's 13F filing for Q2 2018, filed 13 Aug 2018.